The global market for Flubendazole API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Flubendazole API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Flubendazole API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Flubendazole API include Hangzhou Longshine Bio-Tech, FENGCHEN GROUP, Tecoland, Johnson & Johnson Innovative Medicine, Changzhou Yabang, Alivira Animal Health, Shaanxi Hanjiang pharmaceutical Group, Chr. Olesen Group, Janssen Pharma, Procurenet, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Flubendazole API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flubendazole API.

The Flubendazole API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flubendazole API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Flubendazole API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Flubendazole API Market Report

Report Metric	Details
Report Name	Flubendazole API Market
Segment by Type	Purity 99% Purity 98%
Segment by Application	Human Medication Veterinary Medication
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Hangzhou Longshine Bio-Tech, FENGCHEN GROUP, Tecoland, Johnson & Johnson Innovative Medicine, Changzhou Yabang, Alivira Animal Health, Shaanxi Hanjiang pharmaceutical Group, Chr. Olesen Group, Janssen Pharma, Procurenet, Clearsynth, Pharmaffiliates, Enomark
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Flubendazole API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Flubendazole API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Flubendazole API Market report?

Ans: The main players in the Flubendazole API Market are Hangzhou Longshine Bio-Tech, FENGCHEN GROUP, Tecoland, Johnson & Johnson Innovative Medicine, Changzhou Yabang, Alivira Animal Health, Shaanxi Hanjiang pharmaceutical Group, Chr. Olesen Group, Janssen Pharma, Procurenet, Clearsynth, Pharmaffiliates, Enomark

What are the Application segmentation covered in the Flubendazole API Market report?

Ans: The Applications covered in the Flubendazole API Market report are Human Medication, Veterinary Medication

What are the Type segmentation covered in the Flubendazole API Market report?

Ans: The Types covered in the Flubendazole API Market report are Purity 99%, Purity 98%

1 Flubendazole API Market Overview

1.1 Product Definition

1.2 Flubendazole API by Type

1.2.1 Global Flubendazole API Market Value Comparison by Type (2024 VS 2031)

1.2.2 Purity 99%

1.2.3 Purity 98%

1.3 Flubendazole API by Application

1.3.1 Global Flubendazole API Market Value by Application (2024 VS 2031)

1.3.2 Human Medication

1.3.3 Veterinary Medication

1.4 Global Flubendazole API Market Size Estimates and Forecasts

1.4.1 Global Flubendazole API Revenue 2020-2031

1.4.2 Global Flubendazole API Sales 2020-2031

1.4.3 Global Flubendazole API Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Flubendazole API Market Competition by Manufacturers

2.1 Global Flubendazole API Sales Market Share by Manufacturers (2020-2025)

2.2 Global Flubendazole API Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Flubendazole API Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Flubendazole API, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Flubendazole API, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Flubendazole API, Product Type & Application

2.7 Global Key Manufacturers of Flubendazole API, Date of Enter into This Industry

2.8 Global Flubendazole API Market Competitive Situation and Trends

2.8.1 Global Flubendazole API Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Flubendazole API Players Market Share by Revenue

2.8.3 Global Flubendazole API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Flubendazole API Market Scenario by Region

3.1 Global Flubendazole API Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Flubendazole API Sales by Region: 2020-2031

3.2.1 Global Flubendazole API Sales by Region: 2020-2025

3.2.2 Global Flubendazole API Sales by Region: 2026-2031

3.3 Global Flubendazole API Revenue by Region: 2020-2031

3.3.1 Global Flubendazole API Revenue by Region: 2020-2025

3.3.2 Global Flubendazole API Revenue by Region: 2026-2031

3.4 North America Flubendazole API Market Facts & Figures by Country

3.4.1 North America Flubendazole API Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Flubendazole API Sales by Country (2020-2031)

3.4.3 North America Flubendazole API Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Flubendazole API Market Facts & Figures by Country

3.5.1 Europe Flubendazole API Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Flubendazole API Sales by Country (2020-2031)

3.5.3 Europe Flubendazole API Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Flubendazole API Market Facts & Figures by Region

3.6.1 Asia Pacific Flubendazole API Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Flubendazole API Sales by Region (2020-2031)

3.6.3 Asia Pacific Flubendazole API Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Flubendazole API Market Facts & Figures by Country

3.7.1 Latin America Flubendazole API Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Flubendazole API Sales by Country (2020-2031)

3.7.3 Latin America Flubendazole API Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Flubendazole API Market Facts & Figures by Country

3.8.1 Middle East and Africa Flubendazole API Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Flubendazole API Sales by Country (2020-2031)

3.8.3 Middle East and Africa Flubendazole API Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Flubendazole API Sales by Type (2020-2031)

4.1.1 Global Flubendazole API Sales by Type (2020-2025)

4.1.2 Global Flubendazole API Sales by Type (2026-2031)

4.1.3 Global Flubendazole API Sales Market Share by Type (2020-2031)

4.2 Global Flubendazole API Revenue by Type (2020-2031)

4.2.1 Global Flubendazole API Revenue by Type (2020-2025)

4.2.2 Global Flubendazole API Revenue by Type (2026-2031)

4.2.3 Global Flubendazole API Revenue Market Share by Type (2020-2031)

4.3 Global Flubendazole API Price by Type (2020-2031)

5 Segment by Application

5.1 Global Flubendazole API Sales by Application (2020-2031)

5.1.1 Global Flubendazole API Sales by Application (2020-2025)

5.1.2 Global Flubendazole API Sales by Application (2026-2031)

5.1.3 Global Flubendazole API Sales Market Share by Application (2020-2031)

5.2 Global Flubendazole API Revenue by Application (2020-2031)

5.2.1 Global Flubendazole API Revenue by Application (2020-2025)

5.2.2 Global Flubendazole API Revenue by Application (2026-2031)

5.2.3 Global Flubendazole API Revenue Market Share by Application (2020-2031)

5.3 Global Flubendazole API Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Hangzhou Longshine Bio-Tech

6.1.1 Hangzhou Longshine Bio-Tech Company Information

6.1.2 Hangzhou Longshine Bio-Tech Description and Business Overview

6.1.3 Hangzhou Longshine Bio-Tech Flubendazole API Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Hangzhou Longshine Bio-Tech Flubendazole API Product Portfolio

6.1.5 Hangzhou Longshine Bio-Tech Recent Developments/Updates

6.2 FENGCHEN GROUP

6.2.1 FENGCHEN GROUP Company Information

6.2.2 FENGCHEN GROUP Description and Business Overview

6.2.3 FENGCHEN GROUP Flubendazole API Sales, Revenue and Gross Margin (2020-2025)

6.2.4 FENGCHEN GROUP Flubendazole API Product Portfolio

6.2.5 FENGCHEN GROUP Recent Developments/Updates

6.3 Tecoland

6.3.1 Tecoland Company Information

6.3.2 Tecoland Description and Business Overview

6.3.3 Tecoland Flubendazole API Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Tecoland Flubendazole API Product Portfolio

6.3.5 Tecoland Recent Developments/Updates

6.4 Johnson & Johnson Innovative Medicine

6.4.1 Johnson & Johnson Innovative Medicine Company Information

6.4.2 Johnson & Johnson Innovative Medicine Description and Business Overview

6.4.3 Johnson & Johnson Innovative Medicine Flubendazole API Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Johnson & Johnson Innovative Medicine Flubendazole API Product Portfolio

6.4.5 Johnson & Johnson Innovative Medicine Recent Developments/Updates

6.5 Changzhou Yabang

6.5.1 Changzhou Yabang Company Information

6.5.2 Changzhou Yabang Description and Business Overview

6.5.3 Changzhou Yabang Flubendazole API Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Changzhou Yabang Flubendazole API Product Portfolio

6.5.5 Changzhou Yabang Recent Developments/Updates

6.6 Alivira Animal Health

6.6.1 Alivira Animal Health Company Information

6.6.2 Alivira Animal Health Description and Business Overview

6.6.3 Alivira Animal Health Flubendazole API Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Alivira Animal Health Flubendazole API Product Portfolio

6.6.5 Alivira Animal Health Recent Developments/Updates

6.7 Shaanxi Hanjiang pharmaceutical Group

6.7.1 Shaanxi Hanjiang pharmaceutical Group Company Information

6.7.2 Shaanxi Hanjiang pharmaceutical Group Description and Business Overview

6.7.3 Shaanxi Hanjiang pharmaceutical Group Flubendazole API Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Shaanxi Hanjiang pharmaceutical Group Flubendazole API Product Portfolio

6.7.5 Shaanxi Hanjiang pharmaceutical Group Recent Developments/Updates

6.8 Chr. Olesen Group

6.8.1 Chr. Olesen Group Company Information

6.8.2 Chr. Olesen Group Description and Business Overview

6.8.3 Chr. Olesen Group Flubendazole API Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Chr. Olesen Group Flubendazole API Product Portfolio

6.8.5 Chr. Olesen Group Recent Developments/Updates

6.9 Janssen Pharma

6.9.1 Janssen Pharma Company Information

6.9.2 Janssen Pharma Description and Business Overview

6.9.3 Janssen Pharma Flubendazole API Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Janssen Pharma Flubendazole API Product Portfolio

6.9.5 Janssen Pharma Recent Developments/Updates

6.10 Procurenet

6.10.1 Procurenet Company Information

6.10.2 Procurenet Description and Business Overview

6.10.3 Procurenet Flubendazole API Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Procurenet Flubendazole API Product Portfolio

6.10.5 Procurenet Recent Developments/Updates

6.11 Clearsynth

6.11.1 Clearsynth Company Information

6.11.2 Clearsynth Description and Business Overview

6.11.3 Clearsynth Flubendazole API Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Clearsynth Flubendazole API Product Portfolio

6.11.5 Clearsynth Recent Developments/Updates

6.12 Pharmaffiliates

6.12.1 Pharmaffiliates Company Information

6.12.2 Pharmaffiliates Description and Business Overview

6.12.3 Pharmaffiliates Flubendazole API Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Pharmaffiliates Flubendazole API Product Portfolio

6.12.5 Pharmaffiliates Recent Developments/Updates

6.13 Enomark

6.13.1 Enomark Company Information

6.13.2 Enomark Description and Business Overview

6.13.3 Enomark Flubendazole API Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Enomark Flubendazole API Product Portfolio

6.13.5 Enomark Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Flubendazole API Industry Chain Analysis

7.2 Flubendazole API Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Flubendazole API Production Mode & Process Analysis

7.4 Flubendazole API Sales and Marketing

7.4.1 Flubendazole API Sales Channels

7.4.2 Flubendazole API Distributors

7.5 Flubendazole API Customer Analysis

8 Flubendazole API Market Dynamics

8.1 Flubendazole API Industry Trends

8.2 Flubendazole API Market Drivers

8.3 Flubendazole API Market Challenges

8.4 Flubendazole API Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Vendors

Hangzhou Longshine Bio-Tech

Fengchen Group

Tecoland

Johnson & Johnson Innovative Medicine

Changzhou Yabang

Alivira Animal Health

Shaanxi Hanjiang Pharmaceutical Group

List of Tables

Table 1. Global Flubendazole API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Flubendazole API Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Flubendazole API Market Competitive Situation by Manufacturers in 2024

Table 4. Global Flubendazole API Sales (Tons) of Key Manufacturers (2020-2025)

Table 5. Global Flubendazole API Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Flubendazole API Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Flubendazole API Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Flubendazole API Average Price (US$/Ton) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Flubendazole API, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Flubendazole API, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Flubendazole API, Product Type & Application

Table 12. Global Key Manufacturers of Flubendazole API, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Flubendazole API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flubendazole API as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Flubendazole API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Flubendazole API Sales by Region (2020-2025) & (Tons)

Table 18. Global Flubendazole API Sales Market Share by Region (2020-2025)

Table 19. Global Flubendazole API Sales by Region (2026-2031) & (Tons)

Table 20. Global Flubendazole API Sales Market Share by Region (2026-2031)

Table 21. Global Flubendazole API Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Flubendazole API Revenue Market Share by Region (2020-2025)

Table 23. Global Flubendazole API Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Flubendazole API Revenue Market Share by Region (2026-2031)

Table 25. North America Flubendazole API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Flubendazole API Sales by Country (2020-2025) & (Tons)

Table 27. North America Flubendazole API Sales by Country (2026-2031) & (Tons)

Table 28. North America Flubendazole API Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Flubendazole API Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Flubendazole API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Flubendazole API Sales by Country (2020-2025) & (Tons)

Table 32. Europe Flubendazole API Sales by Country (2026-2031) & (Tons)

Table 33. Europe Flubendazole API Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Flubendazole API Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Flubendazole API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Flubendazole API Sales by Region (2020-2025) & (Tons)

Table 37. Asia Pacific Flubendazole API Sales by Region (2026-2031) & (Tons)

Table 38. Asia Pacific Flubendazole API Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Flubendazole API Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Flubendazole API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Flubendazole API Sales by Country (2020-2025) & (Tons)

Table 42. Latin America Flubendazole API Sales by Country (2026-2031) & (Tons)

Table 43. Latin America Flubendazole API Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Flubendazole API Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Flubendazole API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Flubendazole API Sales by Country (2020-2025) & (Tons)

Table 47. Middle East and Africa Flubendazole API Sales by Country (2026-2031) & (Tons)

Table 48. Middle East and Africa Flubendazole API Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Flubendazole API Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Flubendazole API Sales (Tons) by Type (2020-2025)

Table 51. Global Flubendazole API Sales (Tons) by Type (2026-2031)

Table 52. Global Flubendazole API Sales Market Share by Type (2020-2025)

Table 53. Global Flubendazole API Sales Market Share by Type (2026-2031)

Table 54. Global Flubendazole API Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Flubendazole API Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Flubendazole API Revenue Market Share by Type (2020-2025)

Table 57. Global Flubendazole API Revenue Market Share by Type (2026-2031)

Table 58. Global Flubendazole API Price (US$/Ton) by Type (2020-2025)

Table 59. Global Flubendazole API Price (US$/Ton) by Type (2026-2031)

Table 60. Global Flubendazole API Sales (Tons) by Application (2020-2025)

Table 61. Global Flubendazole API Sales (Tons) by Application (2026-2031)

Table 62. Global Flubendazole API Sales Market Share by Application (2020-2025)

Table 63. Global Flubendazole API Sales Market Share by Application (2026-2031)

Table 64. Global Flubendazole API Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Flubendazole API Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Flubendazole API Revenue Market Share by Application (2020-2025)

Table 67. Global Flubendazole API Revenue Market Share by Application (2026-2031)

Table 68. Global Flubendazole API Price (US$/Ton) by Application (2020-2025)

Table 69. Global Flubendazole API Price (US$/Ton) by Application (2026-2031)

Table 70. Hangzhou Longshine Bio-Tech Company Information

Table 71. Hangzhou Longshine Bio-Tech Description and Business Overview

Table 72. Hangzhou Longshine Bio-Tech Flubendazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Hangzhou Longshine Bio-Tech Flubendazole API Product

Table 74. Hangzhou Longshine Bio-Tech Recent Developments/Updates

Table 75. FENGCHEN GROUP Company Information

Table 76. FENGCHEN GROUP Description and Business Overview

Table 77. FENGCHEN GROUP Flubendazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. FENGCHEN GROUP Flubendazole API Product

Table 79. FENGCHEN GROUP Recent Developments/Updates

Table 80. Tecoland Company Information

Table 81. Tecoland Description and Business Overview

Table 82. Tecoland Flubendazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Tecoland Flubendazole API Product

Table 84. Tecoland Recent Developments/Updates

Table 85. Johnson & Johnson Innovative Medicine Company Information

Table 86. Johnson & Johnson Innovative Medicine Description and Business Overview

Table 87. Johnson & Johnson Innovative Medicine Flubendazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Johnson & Johnson Innovative Medicine Flubendazole API Product

Table 89. Johnson & Johnson Innovative Medicine Recent Developments/Updates

Table 90. Changzhou Yabang Company Information

Table 91. Changzhou Yabang Description and Business Overview

Table 92. Changzhou Yabang Flubendazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Changzhou Yabang Flubendazole API Product

Table 94. Changzhou Yabang Recent Developments/Updates

Table 95. Alivira Animal Health Company Information

Table 96. Alivira Animal Health Description and Business Overview

Table 97. Alivira Animal Health Flubendazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Alivira Animal Health Flubendazole API Product

Table 99. Alivira Animal Health Recent Developments/Updates

Table 100. Shaanxi Hanjiang pharmaceutical Group Company Information

Table 101. Shaanxi Hanjiang pharmaceutical Group Description and Business Overview

Table 102. Shaanxi Hanjiang pharmaceutical Group Flubendazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. Shaanxi Hanjiang pharmaceutical Group Flubendazole API Product

Table 104. Shaanxi Hanjiang pharmaceutical Group Recent Developments/Updates

Table 105. Chr. Olesen Group Company Information

Table 106. Chr. Olesen Group Description and Business Overview

Table 107. Chr. Olesen Group Flubendazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. Chr. Olesen Group Flubendazole API Product

Table 109. Chr. Olesen Group Recent Developments/Updates

Table 110. Janssen Pharma Company Information

Table 111. Janssen Pharma Description and Business Overview

Table 112. Janssen Pharma Flubendazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. Janssen Pharma Flubendazole API Product

Table 114. Janssen Pharma Recent Developments/Updates

Table 115. Procurenet Company Information

Table 116. Procurenet Description and Business Overview

Table 117. Procurenet Flubendazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. Procurenet Flubendazole API Product

Table 119. Procurenet Recent Developments/Updates

Table 120. Clearsynth Company Information

Table 121. Clearsynth Description and Business Overview

Table 122. Clearsynth Flubendazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 123. Clearsynth Flubendazole API Product

Table 124. Clearsynth Recent Developments/Updates

Table 125. Pharmaffiliates Company Information

Table 126. Pharmaffiliates Description and Business Overview

Table 127. Pharmaffiliates Flubendazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 128. Pharmaffiliates Flubendazole API Product

Table 129. Pharmaffiliates Recent Developments/Updates

Table 130. Enomark Company Information

Table 131. Enomark Description and Business Overview

Table 132. Enomark Flubendazole API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 133. Enomark Flubendazole API Product

Table 134. Enomark Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Flubendazole API Distributors List

Table 138. Flubendazole API Customers List

Table 139. Flubendazole API Market Trends

Table 140. Flubendazole API Market Drivers

Table 141. Flubendazole API Market Challenges

Table 142. Flubendazole API Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Flubendazole API

Figure 2. Global Flubendazole API Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Flubendazole API Market Share by Type: 2024 & 2031

Figure 4. Purity 99% Product Picture

Figure 5. Purity 98% Product Picture

Figure 6. Global Flubendazole API Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Flubendazole API Market Share by Application: 2024 & 2031

Figure 8. Human Medication

Figure 9. Veterinary Medication

Figure 10. Global Flubendazole API Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Flubendazole API Market Size (2020-2031) & (US$ Million)

Figure 12. Global Flubendazole API Sales (2020-2031) & (Tons)

Figure 13. Global Flubendazole API Average Price (US$/Ton) & (2020-2031)

Figure 14. Flubendazole API Report Years Considered

Figure 15. Flubendazole API Sales Share by Manufacturers in 2024

Figure 16. Global Flubendazole API Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Flubendazole API Players: Market Share by Revenue in Flubendazole API in 2024

Figure 18. Flubendazole API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Flubendazole API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Flubendazole API Sales Market Share by Country (2020-2031)

Figure 21. North America Flubendazole API Revenue Market Share by Country (2020-2031)

Figure 22. United States Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Flubendazole API Sales Market Share by Country (2020-2031)

Figure 25. Europe Flubendazole API Revenue Market Share by Country (2020-2031)

Figure 26. Germany Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Flubendazole API Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Flubendazole API Revenue Market Share by Region (2020-2031)

Figure 33. China Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America Flubendazole API Sales Market Share by Country (2020-2031)

Figure 41. Latin America Flubendazole API Revenue Market Share by Country (2020-2031)

Figure 42. Mexico Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Middle East and Africa Flubendazole API Sales Market Share by Country (2020-2031)

Figure 46. Middle East and Africa Flubendazole API Revenue Market Share by Country (2020-2031)

Figure 47. Turkey Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. UAE Flubendazole API Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Global Sales Market Share of Flubendazole API by Type (2020-2031)

Figure 51. Global Revenue Market Share of Flubendazole API by Type (2020-2031)

Figure 52. Global Flubendazole API Price (US$/Ton) by Type (2020-2031)

Figure 53. Global Sales Market Share of Flubendazole API by Application (2020-2031)

Figure 54. Global Revenue Market Share of Flubendazole API by Application (2020-2031)

Figure 55. Global Flubendazole API Price (US$/Ton) by Application (2020-2031)

Figure 56. Flubendazole API Value Chain

Figure 57. Channels of Distribution (Direct Vs Distribution)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions